U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
DEPATUXIZUMAB
W984C353CG
Investigational
General
Names
10
Classification
2
Identifiers
7
Subunits
4
Related Substances
1
DEPATUXIZUMAB
W984C353CG
Investigational
General
Approval Year
Unknown
139,594
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
DEPATUXIZUMAB
Official Name
English
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 LIGHT CHAIN, DIMER
Common Name
English
Depatuxizumab [WHO-DD]
Common Name
English
ABT-806
Code
English
ANTI-EGFR MAB ABT-806
Common Name
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of glioblastoma multiforme
FDA ORPHAN DRUG
361811
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NCI_THESAURUS
C95206
PRIMARY
USAN
CD-13
PRIMARY
DRUG BANK
DB12826
PRIMARY
ChEMBL
CHEMBL3707294
PRIMARY
CAS
1471999-69-5
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
W984C353CG
DEPATUXIZUMAB